195 related articles for article (PubMed ID: 19632985)
1. New activation modus of STAT3: a tyrosine-less region of the interleukin-22 receptor recruits STAT3 by interacting with its coiled-coil domain.
Dumoutier L; de Meester C; Tavernier J; Renauld JC
J Biol Chem; 2009 Sep; 284(39):26377-84. PubMed ID: 19632985
[TBL] [Abstract][Full Text] [Related]
2. The coiled-coil domain of Stat3 is essential for its SH2 domain-mediated receptor binding and subsequent activation induced by epidermal growth factor and interleukin-6.
Zhang T; Kee WH; Seow KT; Fung W; Cao X
Mol Cell Biol; 2000 Oct; 20(19):7132-9. PubMed ID: 10982829
[TBL] [Abstract][Full Text] [Related]
3. Identification of canonical tyrosine-dependent and non-canonical tyrosine-independent STAT3 activation sites in the intracellular domain of the interleukin 23 receptor.
Floss DM; Mrotzek S; Klöcker T; Schröder J; Grötzinger J; Rose-John S; Scheller J
J Biol Chem; 2013 Jul; 288(27):19386-400. PubMed ID: 23673666
[TBL] [Abstract][Full Text] [Related]
4. A single tyrosine of the interleukin-9 (IL-9) receptor is required for STAT activation, antiapoptotic activity, and growth regulation by IL-9.
Demoulin JB; Uyttenhove C; Van Roost E; DeLestré B; Donckers D; Van Snick J; Renauld JC
Mol Cell Biol; 1996 Sep; 16(9):4710-6. PubMed ID: 8756628
[TBL] [Abstract][Full Text] [Related]
5. Stat3 recruitment by two distinct ligand-induced, tyrosine-phosphorylated docking sites in the interleukin-10 receptor intracellular domain.
Weber-Nordt RM; Riley JK; Greenlund AC; Moore KW; Darnell JE; Schreiber RD
J Biol Chem; 1996 Nov; 271(44):27954-61. PubMed ID: 8910398
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.
Lejeune D; Demoulin JB; Renauld JC
Biochem J; 2001 Jan; 353(Pt 1):109-116. PubMed ID: 11115404
[TBL] [Abstract][Full Text] [Related]
7. Association of STAT1, STAT3 and STAT5 proteins with the IL-2 receptor involves different subdomains of the IL-2 receptor beta chain.
Delespine-Carmagnat M; Bouvier G; Bertoglio J
Eur J Immunol; 2000 Jan; 30(1):59-68. PubMed ID: 10602027
[TBL] [Abstract][Full Text] [Related]
8. Activation of the STAT3/acute phase response factor transcription factor by interleukin-5.
Caldenhoven E; van Dijk T; Raaijmakers JA; Lammers JW; Koenderman L; De Groot RP
J Biol Chem; 1995 Oct; 270(43):25778-84. PubMed ID: 7592760
[TBL] [Abstract][Full Text] [Related]
9. STAT3 signal transduction through interleukin-22 in oral squamous cell carcinoma.
Naher L; Kiyoshima T; Kobayashi I; Wada H; Nagata K; Fujiwara H; Ookuma YF; Ozeki S; Nakamura S; Sakai H
Int J Oncol; 2012 Nov; 41(5):1577-86. PubMed ID: 22922995
[TBL] [Abstract][Full Text] [Related]
10. Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling.
Dumoutier L; Tounsi A; Michiels T; Sommereyns C; Kotenko SV; Renauld JC
J Biol Chem; 2004 Jul; 279(31):32269-74. PubMed ID: 15166220
[TBL] [Abstract][Full Text] [Related]
11. Heteromerization of the gammac chain with the interleukin-9 receptor alpha subunit leads to STAT activation and prevention of apoptosis.
Bauer JH; Liu KD; You Y; Lai SY; Goldsmith MA
J Biol Chem; 1998 Apr; 273(15):9255-60. PubMed ID: 9535918
[TBL] [Abstract][Full Text] [Related]
12. Defining the functional binding sites of interleukin 12 receptor β1 and interleukin 23 receptor to Janus kinases.
Floss DM; Klöcker T; Schröder J; Lamertz L; Mrotzek S; Strobl B; Hermanns H; Scheller J
Mol Biol Cell; 2016 Jul; 27(14):2301-16. PubMed ID: 27193299
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase C delta associates with the interleukin-6 receptor subunit glycoprotein (gp) 130 via Stat3 and enhances Stat3-gp130 interaction.
Novotny-Diermayr V; Zhang T; Gu L; Cao X
J Biol Chem; 2002 Dec; 277(51):49134-42. PubMed ID: 12361954
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of the interleukin-11 receptor and evidence of STAT3 activation in prostate carcinoma.
Campbell CL; Jiang Z; Savarese DM; Savarese TM
Am J Pathol; 2001 Jan; 158(1):25-32. PubMed ID: 11141475
[TBL] [Abstract][Full Text] [Related]
15. IL-6 signaling via the STAT3/SOCS3 pathway: functional analysis of the conserved STAT3 N-domain.
Zhang L; Badgwell DB; Bevers JJ; Schlessinger K; Murray PJ; Levy DE; Watowich SS
Mol Cell Biochem; 2006 Aug; 288(1-2):179-89. PubMed ID: 16718380
[TBL] [Abstract][Full Text] [Related]
16. The amino acid residues immediately carboxyl-terminal to the tyrosine phosphorylation site contribute to interleukin 6-specific activation of signal transducer and activator of transcription 3.
Inoue M; Minami M; Matsumoto M; Kishimoto T; Akira S
J Biol Chem; 1997 Apr; 272(14):9550-5. PubMed ID: 9083098
[TBL] [Abstract][Full Text] [Related]
17. The carboxyl-terminal region of STAT3 controls gene induction by the mouse haptoglobin promoter.
Kim H; Baumann H
J Biol Chem; 1997 Jun; 272(23):14571-9. PubMed ID: 9169415
[TBL] [Abstract][Full Text] [Related]
18. IL22/IL-22R pathway induces cell survival in human glioblastoma cells.
Akil H; Abbaci A; Lalloué F; Bessette B; Costes LM; Domballe L; Charreau S; Guilloteau K; Karayan-Tapon L; Bernard FX; Morel F; Jauberteau MO; Lecron JC
PLoS One; 2015; 10(3):e0119872. PubMed ID: 25793261
[TBL] [Abstract][Full Text] [Related]
19. Characterization of IL-4 and IL-13 signals dependent on the human IL-13 receptor alpha chain 1: redundancy of requirement of tyrosine residue for STAT3 activation.
Umeshita-Suyama R; Sugimoto R; Akaiwa M; Arima K; Yu B; Wada M; Kuwano M; Nakajima K; Hamasaki N; Izuhara K
Int Immunol; 2000 Nov; 12(11):1499-509. PubMed ID: 11058569
[TBL] [Abstract][Full Text] [Related]
20. Critical cytoplasmic domains of human interleukin-9 receptor alpha chain in interleukin-9-mediated cell proliferation and signal transduction.
Zhu YX; Sun HB; Tsang ML; McMahel J; Grigsby S; Yin T; Yang YC
J Biol Chem; 1997 Aug; 272(34):21334-40. PubMed ID: 9261146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
